Skip to main content

Navigation group

Type at least 3 characters
2,922 articles

Articles

Original Research

Published on 04 Dec 2023

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival

in Molecular and Cellular Oncology

  • Rao Prabhala
  • William E. Pierceall
  • Mehmet Samur
  • Lakshmi B. Potluri
  • Kevin Hong
  • Teresa Peluso
  • Srikanth Talluri
  • Angela Wang
  • Aishwarya Katiki
  • Sahan D. Vangala
Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival
Frontiers in Oncology
doi 10.3389/fonc.2023.1271807
  • 2,086 views
  • 3 citations